SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-17-019162
Filing Date
2017-03-24
Accepted
2017-03-24 16:14:45
Documents
119
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a17-8508_110k.htm 10-K 3534763
2 EX-21 a17-8508_1ex21.htm EX-21 4591
3 EX-23.1 a17-8508_1ex23d1.htm EX-23.1 3699
4 EX-31.1 a17-8508_1ex31d1.htm EX-31.1 25304
5 EX-31.2 a17-8508_1ex31d2.htm EX-31.2 25426
6 EX-32.1 a17-8508_1ex32d1.htm EX-32.1 7635
7 EX-32.2 a17-8508_1ex32d2.htm EX-32.2 7486
14 GRAPHIC g85081byi001.gif GRAPHIC 28315
15 GRAPHIC g85081bki001.jpg GRAPHIC 15026
16 GRAPHIC g85081bii001.gif GRAPHIC 28433
  Complete submission text file 0001104659-17-019162.txt   12533240

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT nbrv-20161231.xml EX-101.INS 2614548
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbrv-20161231.xsd EX-101.SCH 92420
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nbrv-20161231_cal.xml EX-101.CAL 85208
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nbrv-20161231_def.xml EX-101.DEF 323086
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT nbrv-20161231_lab.xml EX-101.LAB 717100
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbrv-20161231_pre.xml EX-101.PRE 612920
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37558 | Film No.: 17712915
SIC: 2834 Pharmaceutical Preparations